In this way, they restored the normal structure of bones.
Already in progress the first tests on a small sample of people, while -depending on the first results – can follow major clinical trials in about five years.
Mesenchymal stem cells have the advantage that they can be transferred from the donor to the recipient, without the need for compatibility between them, thus not rejected by the body of the patient.
Researchers at the University of Toronto and the Hospital of Ottawa, who made the relevant publication in the medical journal “Stem Cells Translational Medicine”, stated surprised by how well the stem cells reintroduced within six months the bones in a normal and fully functional condition. The doctors had hoped for just a improve.
The scientists reported that in the future such treatment can be applied even for the prevention of osteoporosis, which affects more than 200 million people in the world.
Type 1 osteoporosis affects women after menopause, while the type 2 and the two sexes due to an advanced age.
Because of the disease, the bones become thinner, less dense and more fragile, resulting in almost nine million fractures worldwide.
Today there is a to the trade only a drug therapy for osteoporosis type 2, which lasts up to two years.
Treatment with stem cells reverse osteoporosis in old mice
—